Additionally, RA patients were treated with the combination of IL1 and TNF neutralizing drugs but this therapy did not have added value [407], although it seemed promising in preclinical sepsis models and in acute myeloid leukemia [79,408]. This evidence concerns the gene TNF and Sepsis.